Tag: cost reduction strategies
-
Indivior to Delist from London Stock Exchange, Focus on Nasdaq
Pharmaceutical company Indivior has decided to delist from the London Stock Exchange, effective July 25, while maintaining its primary listing on the Nasdaq.…